Literature DB >> 9755357

Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression.

M B Keller1, R J Boland.   

Abstract

This is a review article that describes current data, issues, and controversies regarding long-term maintenance treatment of depression. The authors suggest that the issues represent a public health crisis. This paper will identify the need, from both a health-care and economic perspective, for more research on the efficacy of maintenance treatment for this pernicious and lifelong disorder. Data will be reviewed on the natural course of unipolar depression, focusing on clinical predictors that increase the risk of a relapse or recurrence. This review will include new data from the National Institute of Mental Health Collaborative Depression Study. Failing to achieve adequate maintenance treatment for unipolar recurrent major depression has psychopathological and psychosocial consequences, decreasing work productivity and the quality of a person's life. Published double-blind placebo-controlled studies on continuation treatment of major depression will be reviewed. The two competed double-blind placebo-controlled long-term maintenance studies of recurrent unipolar major depression will be discussed in detail. Despite the positive findings from research done to date, there remain many unresolved questions relating to the maintenance treatment of recurrent unipolar major depression, and the need for research in this area is critical. The paper concludes with recommendations for long-term maintenance treatment of unipolar major depression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9755357     DOI: 10.1016/s0006-3223(98)00110-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  47 in total

1.  Recognizing and Treating the Physical Symptoms of Depression in Primary Care.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

2.  Respiratory sinus arrhythmia reactivity to a sad film predicts depression symptom improvement and symptomatic trajectory.

Authors:  Vanessa Panaite; Alexandra Cowden Hindash; Lauren M Bylsma; Brent J Small; Kristen Salomon; Jonathan Rottenberg
Journal:  Int J Psychophysiol       Date:  2015-12-08       Impact factor: 2.997

Review 3.  Vagus nerve stimulation (VNS) for depression: what do we know now and what should be done next?

Authors:  Ziad Nahas; Carol Burns; Milton J Foust; Baron Short; Tal Herbsman; Mark S George
Journal:  Curr Psychiatry Rep       Date:  2006-12       Impact factor: 5.285

4.  Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosis.

Authors:  Yi-Ting Chou; Aaron N Winn; Donald L Rosenstein; Stacie B Dusetzina
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-03-19       Impact factor: 2.890

5.  Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior.

Authors:  Rebecca A Brachman; Josephine C McGowan; Jennifer N Perusini; Sean C Lim; Thu Ha Pham; Charlene Faye; Alain M Gardier; Indira Mendez-David; Denis J David; René Hen; Christine A Denny
Journal:  Biol Psychiatry       Date:  2015-05-04       Impact factor: 13.382

6.  The public health impact of major depression: a call for interdisciplinary prevention efforts.

Authors:  Katie A McLaughlin
Journal:  Prev Sci       Date:  2011-12

7.  Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, Cameroon.

Authors:  Brian W Pence; Bradley N Gaynes; Julius Atashili; Julie K O'Donnell; Dmitry Kats; Kathryn Whetten; Alfred K Njamnshi; Tabenyang Mbu; Charles Kefie; Shantal Asanji; Peter Ndumbe
Journal:  AIDS Behav       Date:  2014-06

8.  Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after successful acute treatment of mild to moderate depression--rationale and study design.

Authors:  S Kasper; A Dienel; M Kieser
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

9.  Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues.

Authors:  William V Bobo; Richard C Shelton
Journal:  Neuropsychiatr Dis Treat       Date:  2009-07-02       Impact factor: 2.570

Review 10.  Diagnosis and management of panic disorder in older patients.

Authors:  Alastair J Flint; Nadine Gagnon
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.